RATIONALE: Epidemiologic studies have shown that exacerbation of asthma is modulated by environmental endotoxin. High levels of endotoxin are associated with asthma symptoms and the current use of asthma medication. However, the underlying mechanisms by which endotoxin modulates asthma are not completely understood. OBJECTIVES: The aim of the study was to test whether endotoxin enhances the response of individuals with allergic asthma to allergen, and to determine if this interaction is associated with increased numbers of antigen-presenting cells in the airways. METHODS: Seventeen subjects with mild allergic asthma underwent segmental challenge with allergen, endotoxin, and the combination of both in three different lung segments via bronchoscopy. The cellular influx including monocytes, myeloid dendritic cells (mDCs), and plasmacytoid dendritic cells (pDCs), as well as the level of cytokines, were assessed in bronchoalveolar lavage fluid obtained 24 hours after segmental challenge. Monocytes, mDCs, and pDCs were isolated and their capacity to induce T cell proliferation was determined. MEASUREMENTS AND MAIN RESULTS: Endotoxin enhanced the cellular response to allergen. The combination of allergen and endotoxin resulted in increased numbers of total cells, lymphocytes, neutrophils, eosinophils, monocytes, and mDCs, as well as increased levels of lipopolysaccharide-binding protein, IL-1alpha, IL-6, and tumor necrosis factor-alpha in the bronchoalveolar lavage fluid compared with allergen alone. Isolated mDCs but not pDCs induced a strong T cell proliferation in vitro. CONCLUSIONS: Endotoxin augments the allergic inflammation in the lungs of individuals with asthma, and induces an enhanced influx of monocytes and functionally active antigen-presenting mDCs into the respiratory tract.
RATIONALE: Epidemiologic studies have shown that exacerbation of asthma is modulated by environmental endotoxin. High levels of endotoxin are associated with asthma symptoms and the current use of asthma medication. However, the underlying mechanisms by which endotoxin modulates asthma are not completely understood. OBJECTIVES: The aim of the study was to test whether endotoxin enhances the response of individuals with allergic asthma to allergen, and to determine if this interaction is associated with increased numbers of antigen-presenting cells in the airways. METHODS: Seventeen subjects with mild allergic asthma underwent segmental challenge with allergen, endotoxin, and the combination of both in three different lung segments via bronchoscopy. The cellular influx including monocytes, myeloid dendritic cells (mDCs), and plasmacytoid dendritic cells (pDCs), as well as the level of cytokines, were assessed in bronchoalveolar lavage fluid obtained 24 hours after segmental challenge. Monocytes, mDCs, and pDCs were isolated and their capacity to induce T cell proliferation was determined. MEASUREMENTS AND MAIN RESULTS: Endotoxin enhanced the cellular response to allergen. The combination of allergen and endotoxin resulted in increased numbers of total cells, lymphocytes, neutrophils, eosinophils, monocytes, and mDCs, as well as increased levels of lipopolysaccharide-binding protein, IL-1alpha, IL-6, and tumor necrosis factor-alpha in the bronchoalveolar lavage fluid compared with allergen alone. Isolated mDCs but not pDCs induced a strong T cell proliferation in vitro. CONCLUSIONS: Endotoxin augments the allergic inflammation in the lungs of individuals with asthma, and induces an enhanced influx of monocytes and functionally active antigen-presenting mDCs into the respiratory tract.
Authors: Brian Boehlecke; Milan Hazucha; Neil E Alexis; Robert Jacobs; Parker Reist; Philip A Bromberg; David B Peden Journal: J Allergy Clin Immunol Date: 2003-12 Impact factor: 10.793
Authors: N P O'Grady; H L Preas; J Pugin; C Fiuza; M Tropea; D Reda; S M Banks; A F Suffredini Journal: Am J Respir Crit Care Med Date: 2001-06 Impact factor: 21.405
Authors: Anneke Engering; Teunis B H Geijtenbeek; Sandra J van Vliet; Mietske Wijers; Ellis van Liempt; Nicolas Demaurex; Antonio Lanzavecchia; Jack Fransen; Carl G Figdor; Vincent Piguet; Yvette van Kooyk Journal: J Immunol Date: 2002-03-01 Impact factor: 5.422
Authors: Charlotte Braun-Fahrländer; Josef Riedler; Udo Herz; Waltraud Eder; Marco Waser; Leticia Grize; Soyoun Maisch; David Carr; Florian Gerlach; Albrecht Bufe; Roger P Lauener; Rudolf Schierl; Harald Renz; Dennis Nowak; Erika von Mutius Journal: N Engl J Med Date: 2002-09-19 Impact factor: 91.245
Authors: Michelle L Hernandez; John C Lay; Bradford Harris; Charles R Esther; W June Brickey; Philip A Bromberg; David Diaz-Sanchez; Robert B Devlin; Steven R Kleeberger; Neil E Alexis; David B Peden Journal: J Allergy Clin Immunol Date: 2010-09 Impact factor: 10.793
Authors: Michelle L Hernandez; Bradford Harris; John C Lay; Philip A Bromberg; David Diaz-Sanchez; Robert B Devlin; Steven R Kleeberger; Neil E Alexis; David B Peden Journal: Inhal Toxicol Date: 2010-07 Impact factor: 2.724
Authors: Elena N Atochina-Vasserman; Carla Winkler; Helen Abramova; Frank Schaumann; Norbert Krug; Andrew J Gow; Michael F Beers; Jens M Hohlfeld Journal: Am J Respir Crit Care Med Date: 2010-12-03 Impact factor: 21.405